Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Part B Viaskin Peanut 250 mcg	244
Overall Study	STARTED	Part B Placebo	118
Overall Study	STARTED	Part A Viaskin Peanut 250 mcg	21
Overall Study	STARTED	Part A Viaskin Peanut 100 mcg	20
Overall Study	STARTED	Part A Placebo	10
Overall Study	COMPLETED	Part B Viaskin Peanut 250 mcg	208
Overall Study	COMPLETED	Part B Placebo	99
Overall Study	COMPLETED	Part A Viaskin Peanut 250 mcg	17
Overall Study	COMPLETED	Part A Viaskin Peanut 100 mcg	16
Overall Study	COMPLETED	Part A Placebo	9
Overall Study	NOT COMPLETED	Part B Viaskin Peanut 250 mcg	36
Overall Study	NOT COMPLETED	Part B Placebo	19
Overall Study	NOT COMPLETED	Part A Viaskin Peanut 250 mcg	4
Overall Study	NOT COMPLETED	Part A Viaskin Peanut 100 mcg	4
Overall Study	NOT COMPLETED	Part A Placebo	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03211247/flow